Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer

By Djärv Emma   Nyman Jan   Baumann Pia   Ekberg Lars   Høyer Morten   Lax Ingmar   Lewensohn Rolf   Levin Nina   Lund Jo-Åsmund   Morhed Elisabeth   Ericsson Susanne Rehn   Traberg Anders   Wittgren Lena   Johansson Karl-Axel  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 973-977

Informa Healthcare

Access to resources Recommend Favorite

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2- neu -positive breast cancer? A current debate

By Petrelli Fausto  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 401-408

Humana Press, Inc

Access to resources Recommend Favorite

Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)

By Zimmermann Frank   Geinitz Hans   Schill Sabine   Thamm Reinhard   Nieder Carsten   Schratzenstaller Ulrich   Molls Michael  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 796-801

Informa Healthcare

Access to resources Recommend Favorite

Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer

By          

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 597-604

Spandidos Publications

Access to resources Recommend Favorite

The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer

By Minamiya Yoshihiro  

Tumor Biology, Vol. 31, Iss. 6, 2010-12 ,pp. : 673-679

Springer Publishing Company

Access to resources Recommend Favorite